Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXT8OU
|
||||
| Drug Name |
benzyl (S)-1-((R)-2-tert-butoxy-1-cyanoethylamino)-4-methyl-1-oxopentan-2-ylcarbamate
|
||||
| Synonyms |
CHEMBL205948
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C21H31N3O4
|
||||
| Canonical SMILES |
CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](COC(C)(C)C)C#N
|
||||
| InChI |
InChI=1S/C21H31N3O4/c1-15(2)11-18(19(25)23-17(12-22)14-28-21(3,4)5)24-20(26)27-13-16-9-7-6-8-10-16/h6-10,15,17-18H,11,13-14H2,1-5H3,(H,23,25)(H,24,26)/t17-,18+/m1/s1
|
||||
| InChIKey |
HTRJYWNEPLFXGA-MSOLQXFVSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.